Democratic Republic of Congo vs Niger: Access to anti-retroviral drugs, female (%)
Democratic Republic of Congo
78.0%
in 2024
Niger
79.0%
in 2024
Democratic Republic of Congo rank
60th
Niger rank
59th
Access to anti-retroviral drugs, female (%) over time
- Democratic Republic of Congo
- Niger
How they compare
Niger currently reports 79.0% against 78.0% in Democratic Republic of Congo, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Niger ahead.
Democratic Republic of Congo ranks 60th and Niger ranks 59th of 141 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 5.0% | 3.0% | Niger |
| 2010s | 25.7% | 54.5% | 28.8% | Niger |
| 2020s | 70.2% | 83.2% | 13.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Democratic Republic of Congo or Niger?
- Niger, at 79.0% against 78.0% in Democratic Republic of Congo as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Democratic Republic of Congo and Niger?
- 1.0%, with Niger ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Democratic Republic of Congo and Niger rank globally for access to anti-retroviral drugs, female?
- Democratic Republic of Congo ranks 60th and Niger ranks 59th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.